Novo Nordisk
Nihal Gunasinghe possesses extensive experience in Quality Assurance and analytical roles within the pharmaceutical and biotechnology industries. Currently serving as a Quality Assurance professional at Bavarian Nordic since January 2021, Nihal's previous positions include Quality Assurance roles at AGC Biologics, Coloplast, and Novo Nordisk, with significant expertise gained during tenure at Novozymes and LifeCycle Pharma as a Senior Scientist in Analytical Development and QC. Early career highlights include positions at Biogen, Catalent Pharma Solutions, Sanofi, and RECKITT BENCKISER, showcasing a solid foundation in analytical chemistry, validation, and stability testing. Educational qualifications include studies at the University of Hull, Richmond, and Texas Christian University, focusing on medicine and pre-medical studies.
This person is not in any teams
Novo Nordisk
377 followers
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.